Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity.

Ding H, Liu XC, Mei Q, Xu JM, Hu XY, Hu J.

World J Gastroenterol. 2014 Apr 7;20(13):3716-8. doi: 10.3748/wjg.v20.i13.3716.

2.

[A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis].

Kim KH, Kim TN, Jang BI.

Korean J Gastroenterol. 2007 Dec;50(6):379-83. Korean.

3.

Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study.

Watanabe M, Nishino H, Sameshima Y, Ota A, Nakamura S, Hibi T.

Aliment Pharmacol Ther. 2013 Aug;38(3):264-73. doi: 10.1111/apt.12362. Epub 2013 Jun 5.

4.

Mesalamine treatment mimicking relapse in a child with ulcerative colitis.

Hojsak I, Pavić AM, Kolaček S.

World J Pediatr. 2014 Nov;10(4):371-3. doi: 10.1007/s12519-014-0485-x. Epub 2014 Jun 28.

PMID:
24974209
5.

The role of aminosalicylates in the treatment of ulcerative colitis.

Van Assche G, Baert F, De Reuck M, De Vos M, De Wit O, Hoang P, Louis E, Mana F, Pelckmans P, Rutgeerts P, Van Gossum A, D'Haens G.

Acta Gastroenterol Belg. 2002 Oct-Dec;65(4):196-9.

PMID:
12619425
6.

Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.

Andus T, Kocjan A, Müser M, Baranovsky A, Mikhailova TL, Zvyagintseva TD, Dorofeyev AE, Lozynskyy YS, Cascorbi I, Stolte M, Vieth M, Dilger K, Mohrbacher R, Greinwald R; International Salofalk Suppository OD Study Group.

Inflamm Bowel Dis. 2010 Nov;16(11):1947-56. doi: 10.1002/ibd.21258.

PMID:
20310020
7.

Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.

Richter JM, Kushkuley S, Barrett JA, Oster G.

Aliment Pharmacol Ther. 2012 Aug;36(3):248-56. doi: 10.1111/j.1365-2036.2012.05175.x. Epub 2012 Jun 12.

8.

Once-daily mesalamine granules for ulcerative colitis.

Lawlor G, Ahmed A, Moss AC.

Expert Rev Clin Immunol. 2010 Jul;6(4):521-6. doi: 10.1586/eci.10.22.

PMID:
20594123
9.
10.

[Mesalamine-induced hypersensitivity pneumonitis].

Zamir D, Weizman J, Zamir C, Fireman Z, Weiner P.

Harefuah. 1999 Jul;137(1-2):28-30, 87, 86. Hebrew.

PMID:
10959271
11.

[A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis].

Son CN, Lee HL, Joo YW, Lee OY, Han DS, Yoon BC, Choi HS, Hahm JS.

Korean J Gastroenterol. 2008 Sep;52(3):192-5. Korean.

12.

Ulcerative colitis occurring in the course of rheumatoid arthritis: a case successfully treated with mesalamine enema.

Sugisaki K, Honma F, Iwadate H, Shio K, Shioya Y, Fukaya E, Sato K, Saito H, Sekine H, Kobayashi H, Orikasa H, Watanabe H, Sato Y.

Intern Med. 2004 Nov;43(11):1046-50.

13.

Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.

Marshall JK, Irvine EJ.

Am J Gastroenterol. 2000 Jul;95(7):1628-36. Review.

PMID:
10925961
14.

A practical guide to the management of distal ulcerative colitis.

Ardizzone S, Bianchi Porro G.

Drugs. 1998 Apr;55(4):519-42. Review.

PMID:
9561342
15.

Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents.

Heyman MB, Kierkus J, Spénard J, Shbaklo H, Giguere M.

Inflamm Bowel Dis. 2010 Nov;16(11):1931-9. doi: 10.1002/ibd.21256.

16.

Practicality of 5-aminosalicylic suppositories for long-term treatment of inactive distal ulcerative colitis.

Casellas F, Vaquero E, Armengol JR, Malagelada JR.

Hepatogastroenterology. 1999 Jul-Aug;46(28):2343-6.

PMID:
10521994
17.

Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.

Schroeder KW.

Scand J Gastroenterol Suppl. 2002;(236):42-7. Review.

PMID:
12408503
18.

[Case of ulcerative colitis induced by mesalazine with acute aggravated colitis-like symptoms].

Inatsuchi S, Nakajima T, Yoshio Y, Entani A, Okada K.

Nihon Shokakibyo Gakkai Zasshi. 2004 Sep;101(9):989-92. Japanese. No abstract available.

PMID:
15478662
19.

High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.

Yamamoto T, Umegae S, Matsumoto K.

Dig Liver Dis. 2011 May;43(5):386-90. doi: 10.1016/j.dld.2010.11.016. Epub 2010 Dec 30.

PMID:
21195041
20.
Items per page

Supplemental Content

Write to the Help Desk